Clinical Trial Update: Study of ATH434 in Participants with Multiple System Atrophy [Phase 2]

View source ↗

Summary

Phase 2 study of ATH434 in participants with Multiple System Atrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• ATH434

Snippet

Sponsor: Alterity Therapeutics | Conditions: Multiple System Atrophy | Phase 2 | Status: COMPLETED